000 01314 a2200385 4500
005 20250517112836.0
264 0 _c20170501
008 201705s 0 0 fre d
022 _a1776-2561
024 7 _a10.1016/j.pneumo.2016.05.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZapata, E
245 0 0 _a[Prolonged response with paclitaxel after immunotherapy by pembrolizumab in lung cancer].
_h[electronic resource]
260 _bRevue de pneumologie clinique
_cOct 2016
300 _a300-304 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xpathology
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCombined Modality Therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aLung Neoplasms
_xpathology
650 0 4 _aPaclitaxel
_xtherapeutic use
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
700 1 _aMennecier, B
700 1 _aLeduc, C
700 1 _aChatron, E
700 1 _aQuoix, E
773 0 _tRevue de pneumologie clinique
_gvol. 72
_gno. 5
_gp. 300-304
856 4 0 _uhttps://doi.org/10.1016/j.pneumo.2016.05.004
_zAvailable from publisher's website
999 _c26361097
_d26361097